Effects of PIPRA + Prevention

In this QIP we have shown that the implementation of PIPRA (an automated POD risk assessment tool) in combination with non-pharmacological multi-component prevention reduces LOS in medium risk older patients. Read the full paper below.
About the author
DPhil from Oxford in cell biology. I2I Fellow at Oxford Universities Saïd Business School
Benjamin Dodsworth, PhD
Chief Technical/ Scientific Officer, PIPRA AG
Don't miss

Free Delirium E-Learning Platform